IM Cannabis Corp.
IMCC · XNASCIK 1792030fmd_1XR5555A50F3340CB7SJ73J64JManufacturing · Medicinal Chemicals & Botanical ProductsTemplate: Standard
Coverage: Jan 01, 2019 to Dec 31, 2025, 12 periods
| Line item | FY2019 | FY2020 | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|---|---|
| Total revenues | 9 | 16 | 34 | 54 | 49 | 54 | 55 |
| Cost of revenue | 5 | 7 | 25 | 43 | 38 | 46 | 45 |
| Gross profit | 4 | 10 | 6 | 9 | 10 | 8 | 10 |
| Research and development | 0 | 0 | – | – | – | – | – |
| Operating income | (10) | (8) | (23) | (31) | (13) | (10) | (12) |
| Interest expense | 1 | 21 | 1 | 2 | 4 | 5 | 4 |
| Income before taxes | (7) | (28) | (0) | (26) | (9) | (13) | (12) |
| Income tax expense | 0 | 0 | 1 | (1) | 1 | (1) | 0 |
| Net income from continuing operations | (7) | (29) | (1) | (25) | (10) | (12) | (12) |
| Net income | (7) | (29) | (18) | (189) | (9) | (11) | (11) |
| Net income to common shareholders | 0 | (29) | (18) | (23) | (9) | (11) | – |